PharmTech Talk

Mar 31, 2015
Statistics presented in a March webinar suggest a strong, but highly fragmented, small-molecule API market
Pharmaceutical Technology: Mar 30, 2015
Commissioner Margaret Hamburg discusses globalization challenges and the need for investment in regulatory science during her last weeks at the agency.
Pharmaceutical Technology: Mar 30, 2015
Drug makers back alternative to FDA labeling update rule.
Pharmaceutical Technology: Mar 26, 2015
By Pharmaceutical Technology Editors
The WHO report outlines possible policies that may help governments reduce the high prices of new medicines.
Mar 04, 2015
By Pharmaceutical Technology Editors
Survey reveals pharmaceutical and medical attitudes towards “KOL” terminology.
Mar 02, 2015
Every now and then, you will hear about the rising costs of R&D, which in turn, translate into high prices for new drugs entering the market.
Pharmaceutical Technology: Feb 24, 2015
Drug shortages are declining, but they’re still a serious concern for regulatory authorities, policy makers, and bio/pharmaceutical manufacturers.
Feb 18, 2015
QbD represents a breakthrough in thinking, but does it go far enough to address today's business challenges? NeoStem has expanded it to include business and market issues, in "Development by Design." Could this be (or is it becoming) a new model for pharma?
Pharmaceutical Technology: Feb 17, 2015
The ongoing battle over drug reimbursement and pricing has raised questions about whether the pharmaceutical industry can continue to rely on high United States revenues to fund biopharmaceutical R&D.
Pharmaceutical Technology: Feb 11, 2015
The industry reacts to the departure of Commissioner Margaret Hamburg.